Line 33: | Line 33: | ||
<td>pSB1C3</td> | <td>pSB1C3</td> | ||
<td> A gene that produces produces a protein which competitively inhibits TSH and auto-immune antibodies in Graves' disease. This variant <b>does</b> have His-tags for purification</td> | <td> A gene that produces produces a protein which competitively inhibits TSH and auto-immune antibodies in Graves' disease. This variant <b>does</b> have His-tags for purification</td> | ||
− | <td> | + | <td>832bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 40: | Line 40: | ||
<td>pSB1C3</td> | <td>pSB1C3</td> | ||
<td>An inducible promoter that responds to the presence of jasmonic acid in the cell</td> | <td>An inducible promoter that responds to the presence of jasmonic acid in the cell</td> | ||
− | <td> | + | <td>522bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 47: | Line 47: | ||
<td>pSB1C3</td> | <td>pSB1C3</td> | ||
<td>An inducible promoter that responds to the presence of salicylic acid in the cell</td> | <td>An inducible promoter that responds to the presence of salicylic acid in the cell</td> | ||
− | <td> | + | <td>519bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 54: | Line 54: | ||
<td>pSB1C3</td> | <td>pSB1C3</td> | ||
<td>An inducible promoter that responds to the presence of salicylic acid in the cell</td> | <td>An inducible promoter that responds to the presence of salicylic acid in the cell</td> | ||
− | <td> | + | <td>519bp</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 61: | Line 61: | ||
<td>pSB1C3</td> | <td>pSB1C3</td> | ||
<td>An inducible promoter that responds to the presence of cellulose-derived oligomers</td> | <td>An inducible promoter that responds to the presence of cellulose-derived oligomers</td> | ||
− | <td> | + | <td>507bp</td> |
</tr> | </tr> | ||
<tr> | <tr> |
Revision as of 12:16, 6 October 2017